Skip to main content

Bellevue Group AG

Position in KRYS — Krystal Biotech, Inc.

CIK 1674546 Zurich, V8

Position in KRYS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,815,575
-$95,639,126 QoQ
Shares Held
77,530
-83.9% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#46
of 419 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KRYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. KRYS ranks #24 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KRYS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,815,575 77,530
2026-03-31 $124,454,701 481,785
2025-12-31 $101,161,031 410,323
2025-09-30 $231,607 1,312
2025-06-30 $171,825 1,250
2025-03-31 $477,795 2,650
2024-12-31 $790,663 5,047
2024-09-30 $869,921 4,779
2024-06-30 $770,920 4,198
2024-03-31 $855,843 4,810
2023-12-31 $992,480 8,000
2023-09-30 $1,450,000 12,500
2023-06-30 $2,113,200 18,000
2023-03-31 $1,465,098 18,300
2022-12-31 $1,449,726 18,300
2022-09-30 $1,275,510 18,300
2022-06-30 $879,844 13,400
2022-03-31 $918,252 13,800
2021-12-31 $979,300 14,000